• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Griffith University in Australia is looking for patients who have taken low-dose naltrexone

Marylib

Senior Member
Messages
1,158
๐—ก๐—–๐—ก๐—˜๐—— ๐˜€๐—ฒ๐—ฒ๐—ธ๐—ถ๐—ป๐—ด ๐— ๐—˜/๐—–๐—™๐—ฆ ๐—ฝ๐—ฎ๐—ฟ๐˜๐—ถ๐—ฐ๐—ถ๐—ฝ๐—ฎ๐—ป๐˜๐˜€ ๐˜„๐—ต๐—ผ ๐—ฎ๐—ฟ๐—ฒ ๐—ฐ๐˜‚๐—ฟ๐—ฟ๐—ฒ๐—ป๐˜๐—น๐˜† ๐˜๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐—Ÿ๐—ผ๐˜„ ๐——๐—ผ๐˜€๐—ฒ ๐—ก๐—ฎ๐—น๐˜๐—ฟ๐—ฒ๐˜…๐—ผ๐—ป๐—ฒ (๐—Ÿ๐——๐—ก)
NCNED would like to hear from ME/CFS patients who are currently taking LDN. If you are a ME/CFS patient taking LDN and would consider participating in a research program please contact NCNED.
For further information please email ncned@griffith.edu.au or call (07) 56789283.